The first BHF Annual Conference, titled COVID-19 and Cardiovascular Health: Reflections and the Future, took place virtually on Thursday 27 May for our external stakeholders. The event explores the challenges and opportunities that the COVID-19 pandemic has raised for cardiovascular patients and research community.
EVENT AGENDA AND TIMES:
02:33 – Protecting the BHF’s research mission – Dr Charmaine Griffiths, BHF Chief Executive
13:33 – Putting patients and public at the heart of what we do – Dr Sonya Babu-Narayan, BHF Associate Medical Director
23:49 – BHF’s patient first response – Professor Keith Channon BHF Professor, University of Oxford and Chair, NIHR-BHF Cardiovascular Partnership
36:38 – Why are individuals with CVD at higher risk of COVID-19 with severe outcomes? – Professor Aroon Hingorani, Director of the UCL Institute of Cardiovascular Science
51:46 – How does COVID-19 affect the cardiovascular system in the short and long term? – Professor Marc Dweck, BHF Senior Research Fellow University of Edinburgh
1:25:45 – The long-term impact of the COVID-19 pandemic on care of CVD patients? – Professor Barbara Casadei, BHF Professor of Cardiovascular Medicine, University of Oxford
Panel discussion: Living with COVID-19 – What does the future hold?
1:44:55 – Professor Chris Brightling, PHOSP-COVID-19 Principal Investigator
1:49:07 – Professor Patrick Chinnery, Clinical Director, Medical Research Council
1:55:55 – Professor Nick Linker, National Clinical Director for Heart Disease, NHS England and NHS Improvement
2:02:14 – Professor Cathie Sudlow OBE, Director of the BHF Data Science Centre
2:07:29 – professor Andrew Pollard, Professor of Paediatric Infection and Immunity, Department of Paediatrics, University of Oxford – Oxford Vaccine Group
Please note that Professor Chris Whitty, Chief Medical Officer (CMO) for England is not included in this recording.
All information in this video was correct at time of recording.
For more information about the BHF Annual Conference, visit bhf.org.uk/annualconference